GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
Publication
, Journal Article
Chang, SM; Reynolds, SL; Butowski, N; Lamborn, KR; Buckner, JC; Kaplan, RS; Bigner, DD
Published in: Neuro Oncol
October 2005
We present guidelines to standardize the reporting of phase 1 and phase 2 neuro-oncology trials. The guidelines are also intended to assist with accurate interpretation of results from these trials, to facilitate the peer-review process, and to expedite the publication of important and accurate manuscripts. Our guidelines are summarized in a checklist format that can be used as a framework from which to construct a phase 1 or 2 clinical trial.
Duke Scholars
Published In
Neuro Oncol
DOI
ISSN
1522-8517
Publication Date
October 2005
Volume
7
Issue
4
Start / End Page
425 / 434
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Nervous System Neoplasms
- Humans
- Data Interpretation, Statistical
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase I as Topic
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chang, S. M., Reynolds, S. L., Butowski, N., Lamborn, K. R., Buckner, J. C., Kaplan, R. S., & Bigner, D. D. (2005). GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol, 7(4), 425–434. https://doi.org/10.1215/S1152851705000554
Chang, Susan M., Sharon L. Reynolds, Nicholas Butowski, Kathleen R. Lamborn, Jan C. Buckner, Richard S. Kaplan, and Darell D. Bigner. “GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.” Neuro Oncol 7, no. 4 (October 2005): 425–34. https://doi.org/10.1215/S1152851705000554.
Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, et al. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol. 2005 Oct;7(4):425–34.
Chang, Susan M., et al. “GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.” Neuro Oncol, vol. 7, no. 4, Oct. 2005, pp. 425–34. Pubmed, doi:10.1215/S1152851705000554.
Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, Bigner DD. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol. 2005 Oct;7(4):425–434.
Published In
Neuro Oncol
DOI
ISSN
1522-8517
Publication Date
October 2005
Volume
7
Issue
4
Start / End Page
425 / 434
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Nervous System Neoplasms
- Humans
- Data Interpretation, Statistical
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase I as Topic
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences